Sandy Springs, GA
Migraine Treatment clinics in Sandy Springs
Sandy Springs has 3 providers offering migraine care, spanning conventional neurology and regenerative or integrative options. The conventional stack includes triptans, CGRP inhibitors like Aimovig, Emgality, Ajovy, and Nurtec ODT, and onabotulinumtoxinA (Botox) for chronic migraine, which is FDA-approved for that indication. On the regenerative and device side, eNeura's sTMS mini is FDA-cleared for acute and preventive treatment of migraine with aura. Occipital and sphenopalatine ganglion nerve blocks are commonly used off-label in Sandy Springs clinics, typical cost 150 to 400 dollars per injection. PRP scalp injections and neurofeedback are offered by some integrative practices, though evidence for PRP in migraine is Insufficient. Georgia insurers generally cover CGRP inhibitors and Botox for chronic migraine (15 or more headache days per month) when step therapy is documented. A reputable Sandy Springs migraine clinic will start with a neurology evaluation, headache diary, and imaging when red flags are present before escalating to device or procedural options.
Pain Management & Rehab
- PRP Therapy
- Shockwave Therapy
- Arthritis Treatment
- Migraine Treatment
- Stem Cell Therapy
Regulatory context
A note on Georgia's migraine treatment rules.
Repetitive transcranial magnetic stimulation (rTMS) is regulated as a Class II prescription device. The first 510(k) clearance went to NeuroStar in 2008 for treatment-resistant major depressive disorder. Subsequent clearances expanded the on-label scope to obsessive-compulsive disorder (BrainsWay deep TMS, 2018), smoking cessation (BrainsWay, 2020), anxious depression as an adjunct indication (2021), and migraine via single-pulse TMS devices such as eNeura SpringTMS and SAVI Dual. Biofeedback instruments are cleared under 21 CFR 882.1425 as Class II devices for relaxation training and stress reduction. EEG-based neurofeedback systems hold 510(k) clearances in the same category. Cranial electrotherapy stimulation, tDCS wellness devices, and many vagus nerve stimulation accessories sold direct to consumers are not cleared as medical devices, and clinical claims beyond cleared indications are off-label.
-
Georgia Medical Practice Act (O.C.G.A. 43-34-20 et seq.)
Defines the practice of medicine and supervision framework for delegated procedures including TMS technician work. -
Georgia Psychologists Licensure Law (O.C.G.A. 43-39-1 et seq.)
Governs licensed psychologists who deliver biofeedback and neurofeedback within scope.
The Georgia Composite Medical Board investigates TMS clinics for supervision deficiencies and off-label advertising for indications such as ADHD or cognitive enhancement. The Georgia attorney general has pursued Fair Business Practices Act actions against neurofeedback providers claiming unproven cures. Wellness clinics offering tDCS or CES devices face scrutiny when marketing implies medical treatment. Georgia insurers and Medicaid typically require documentation of treatment-resistant depression before covering TMS for major depressive disorder.